Got HIV? Plan on a Long Life

HIV-infected people in Africa should plan on being around for a long time, according to a new study, which shows patients who take a combination of HIV medications can expect to live a near-normal lifespan.

Combined antiretroviral therapy (cART) is the use of more than one HIV medication.

The study suggests that those who undergo cART – even in resource-limited settings – should no longer automatically assume an HIV diagnosis is a death sentence.

Released this week, the findings provide much needed hope for those who suffer from HIV.

It was conducted by the British Columbia Centre for Excellence in HIV/AIDS and the University of British Columbia, in Canada.

Dr. Edward Mills, the study’s principal investigator, says HIV-infected people “should plan and prepare for a long and fulfilling life.”

More >>

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below